Keywords: Prana Biotech, Alzheimer's disease, PBT2, Cognition

Prana’s PBT2 directly restores neurons critical to cognition

Article | 22 March 2011

Print This

Australia’s Prana Biotechnology (ASX: PBT) has announced the publication of new data on the ability of PBT2 to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in